Vecchio R, Ferrara M, Mosca F, Messina G, Ignoto A, Di Martino M, Latteri F
Dipartimento di Chirurgia, Università degli Studi di Catania.
G Chir. 1995 May;16(5):253-5.
The Authors evaluated the efficacy of thymopentin in the prevention of post-splenectomy infections. 14 splenectomized patients treated by thymopentin (50 mg s.c. every other day in the 4 weeks following splenectomy) were compared with 14 splenectomized control patients. Clinical evaluations and measurement of CD4 and CD8 lymphocyte subpopulations were made preoperatively and then after 3 and 6 months from splenectomy. Hyperthermia (37.5-38 degrees C) "sine materia", which disappeared spontaneously in 4-5 weeks, was observed in the post-operative phase in 4 control patients and in 1 patient treated by thymopentin. No statistical difference was demonstrated comparing pre- and post-operative percentages of CD4 and CD8 lymphocytes in the treated and control groups.
作者评估了胸腺五肽预防脾切除术后感染的疗效。将14例接受胸腺五肽治疗的脾切除患者(脾切除术后4周内每隔一天皮下注射50毫克)与14例脾切除对照患者进行比较。术前以及脾切除术后3个月和6个月进行临床评估和CD4及CD8淋巴细胞亚群的测量。4例对照患者和1例接受胸腺五肽治疗的患者在术后出现“无明确病因”的体温过高(37.5 - 38摄氏度),在4 - 5周内自行消失。比较治疗组和对照组术前及术后CD4和CD8淋巴细胞的百分比,未显示出统计学差异。